Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis

C. W. Yang, T. L. Hwang, C. H. Wu, M. S. Wu, P. C. Lai, J. Y. Huang, C. C. Yu, M. H. Shyr, C. C. Huang

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Nitric oxide plays an important role in mediating the inflammatory process. The aim of this study was to evaluate if nitric oxide production was increased during peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD), and the association with the prognosis. The study population comprised 21 patients with 22 episodes of peritonitis. Fifteen patients without peritonitis were controls. Nitrate was measured by HPLC and nitrite by the Griess method, to reflect nitric oxide production. Peritoneal dialysate effluent and plasma were collected from six patients during peritonitis and 1 week after treatment to study changes in dialysate:plasma ratio. In 15 patients, nitrite was measured during peritonitis and every 3 days for 2 weeks or until normalized for evolutional changes. The dialysate:plasma ratios of nitrate and nitrite during peritonitis were reduced 26% and 41.5%, respectively, after 1 week of treatment, indicating the peritoneal production of nitric oxide during peritonitis. In the evolutional study, a 5.1-fold increase of peak nitrite levels in bacterial peritonitis (n = 13) and a 2.5-fold increase in fungal peritonitis (n = 3) were observed compared to controls. Nitrite gradually declined to control levels (9.3 ± 7.2 days) after effective antibiotic treatment, but took longer than to normalize leukocyte count in the peritoneal dialysate effluent (3.9 ± 1.9 days). In four patients with refractory peritonitis (Candida infection in three, Acinetobacter infection in one), the nitrite levels remained elevated 2-fold despite treatment, and the catheters were removed. It is concluded that nitrite levels in peritoneal dialysate effluent may serve as a marker to assess treatment efficacy in CAPD patients with peritonitis.

Original languageEnglish
Pages (from-to)2466-2471
Number of pages6
JournalNephrology Dialysis Transplantation
Volume11
Issue number12
Publication statusPublished - Dec 1996
Externally publishedYes

Fingerprint

Continuous Ambulatory Peritoneal Dialysis
Peritonitis
Nitric Oxide
Nitrites
Dialysis Solutions
Nitrates
Acinetobacter Infections
Therapeutics
Leukocyte Count
Candida
Catheters
High Pressure Liquid Chromatography
Anti-Bacterial Agents

Keywords

  • Continuous ambulatory peritoneal dialysis
  • Nitric oxide
  • Peritonitis

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Yang, C. W., Hwang, T. L., Wu, C. H., Wu, M. S., Lai, P. C., Huang, J. Y., ... Huang, C. C. (1996). Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Nephrology Dialysis Transplantation, 11(12), 2466-2471.

Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. / Yang, C. W.; Hwang, T. L.; Wu, C. H.; Wu, M. S.; Lai, P. C.; Huang, J. Y.; Yu, C. C.; Shyr, M. H.; Huang, C. C.

In: Nephrology Dialysis Transplantation, Vol. 11, No. 12, 12.1996, p. 2466-2471.

Research output: Contribution to journalArticle

Yang, CW, Hwang, TL, Wu, CH, Wu, MS, Lai, PC, Huang, JY, Yu, CC, Shyr, MH & Huang, CC 1996, 'Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis', Nephrology Dialysis Transplantation, vol. 11, no. 12, pp. 2466-2471.
Yang, C. W. ; Hwang, T. L. ; Wu, C. H. ; Wu, M. S. ; Lai, P. C. ; Huang, J. Y. ; Yu, C. C. ; Shyr, M. H. ; Huang, C. C. / Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. In: Nephrology Dialysis Transplantation. 1996 ; Vol. 11, No. 12. pp. 2466-2471.
@article{af1caba3e9434a6680787cfe0ce10db8,
title = "Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis",
abstract = "Nitric oxide plays an important role in mediating the inflammatory process. The aim of this study was to evaluate if nitric oxide production was increased during peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD), and the association with the prognosis. The study population comprised 21 patients with 22 episodes of peritonitis. Fifteen patients without peritonitis were controls. Nitrate was measured by HPLC and nitrite by the Griess method, to reflect nitric oxide production. Peritoneal dialysate effluent and plasma were collected from six patients during peritonitis and 1 week after treatment to study changes in dialysate:plasma ratio. In 15 patients, nitrite was measured during peritonitis and every 3 days for 2 weeks or until normalized for evolutional changes. The dialysate:plasma ratios of nitrate and nitrite during peritonitis were reduced 26{\%} and 41.5{\%}, respectively, after 1 week of treatment, indicating the peritoneal production of nitric oxide during peritonitis. In the evolutional study, a 5.1-fold increase of peak nitrite levels in bacterial peritonitis (n = 13) and a 2.5-fold increase in fungal peritonitis (n = 3) were observed compared to controls. Nitrite gradually declined to control levels (9.3 ± 7.2 days) after effective antibiotic treatment, but took longer than to normalize leukocyte count in the peritoneal dialysate effluent (3.9 ± 1.9 days). In four patients with refractory peritonitis (Candida infection in three, Acinetobacter infection in one), the nitrite levels remained elevated 2-fold despite treatment, and the catheters were removed. It is concluded that nitrite levels in peritoneal dialysate effluent may serve as a marker to assess treatment efficacy in CAPD patients with peritonitis.",
keywords = "Continuous ambulatory peritoneal dialysis, Nitric oxide, Peritonitis",
author = "Yang, {C. W.} and Hwang, {T. L.} and Wu, {C. H.} and Wu, {M. S.} and Lai, {P. C.} and Huang, {J. Y.} and Yu, {C. C.} and Shyr, {M. H.} and Huang, {C. C.}",
year = "1996",
month = "12",
language = "English",
volume = "11",
pages = "2466--2471",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis

AU - Yang, C. W.

AU - Hwang, T. L.

AU - Wu, C. H.

AU - Wu, M. S.

AU - Lai, P. C.

AU - Huang, J. Y.

AU - Yu, C. C.

AU - Shyr, M. H.

AU - Huang, C. C.

PY - 1996/12

Y1 - 1996/12

N2 - Nitric oxide plays an important role in mediating the inflammatory process. The aim of this study was to evaluate if nitric oxide production was increased during peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD), and the association with the prognosis. The study population comprised 21 patients with 22 episodes of peritonitis. Fifteen patients without peritonitis were controls. Nitrate was measured by HPLC and nitrite by the Griess method, to reflect nitric oxide production. Peritoneal dialysate effluent and plasma were collected from six patients during peritonitis and 1 week after treatment to study changes in dialysate:plasma ratio. In 15 patients, nitrite was measured during peritonitis and every 3 days for 2 weeks or until normalized for evolutional changes. The dialysate:plasma ratios of nitrate and nitrite during peritonitis were reduced 26% and 41.5%, respectively, after 1 week of treatment, indicating the peritoneal production of nitric oxide during peritonitis. In the evolutional study, a 5.1-fold increase of peak nitrite levels in bacterial peritonitis (n = 13) and a 2.5-fold increase in fungal peritonitis (n = 3) were observed compared to controls. Nitrite gradually declined to control levels (9.3 ± 7.2 days) after effective antibiotic treatment, but took longer than to normalize leukocyte count in the peritoneal dialysate effluent (3.9 ± 1.9 days). In four patients with refractory peritonitis (Candida infection in three, Acinetobacter infection in one), the nitrite levels remained elevated 2-fold despite treatment, and the catheters were removed. It is concluded that nitrite levels in peritoneal dialysate effluent may serve as a marker to assess treatment efficacy in CAPD patients with peritonitis.

AB - Nitric oxide plays an important role in mediating the inflammatory process. The aim of this study was to evaluate if nitric oxide production was increased during peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD), and the association with the prognosis. The study population comprised 21 patients with 22 episodes of peritonitis. Fifteen patients without peritonitis were controls. Nitrate was measured by HPLC and nitrite by the Griess method, to reflect nitric oxide production. Peritoneal dialysate effluent and plasma were collected from six patients during peritonitis and 1 week after treatment to study changes in dialysate:plasma ratio. In 15 patients, nitrite was measured during peritonitis and every 3 days for 2 weeks or until normalized for evolutional changes. The dialysate:plasma ratios of nitrate and nitrite during peritonitis were reduced 26% and 41.5%, respectively, after 1 week of treatment, indicating the peritoneal production of nitric oxide during peritonitis. In the evolutional study, a 5.1-fold increase of peak nitrite levels in bacterial peritonitis (n = 13) and a 2.5-fold increase in fungal peritonitis (n = 3) were observed compared to controls. Nitrite gradually declined to control levels (9.3 ± 7.2 days) after effective antibiotic treatment, but took longer than to normalize leukocyte count in the peritoneal dialysate effluent (3.9 ± 1.9 days). In four patients with refractory peritonitis (Candida infection in three, Acinetobacter infection in one), the nitrite levels remained elevated 2-fold despite treatment, and the catheters were removed. It is concluded that nitrite levels in peritoneal dialysate effluent may serve as a marker to assess treatment efficacy in CAPD patients with peritonitis.

KW - Continuous ambulatory peritoneal dialysis

KW - Nitric oxide

KW - Peritonitis

UR - http://www.scopus.com/inward/record.url?scp=0030453158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030453158&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 2466

EP - 2471

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 12

ER -